Regulus reports top-line data from early-stage RGLS4326 trial in polycystic kidney disease
May 03 2021 - 8:24AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Apr 2023 to Apr 2024